Filter by: patients
Home > Community Treatment Reports and Side Effects > Ranexa Treatment Report
What is Ranexa?

Ranexa® is a brand of ranolazine, a cardiovascular agent used to treat chronic angina.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Angina pain 3 0
Coronary Artery Disease 2 0
Angina pectoris 1 1 Efficacy_none
pumping of the heart 1 0

See all 6 patients currently taking Ranexa

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Ranexa

Stomach upset 1

Reported Dosages

  500 mg daily 1,000 mg daily 2,000 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Ranexa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1   Expense: 100%

See all 1 patient who’ve stopped taking Ranexa

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Ranexa

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Ranexa

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Ranexa

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Ranexa

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Ranexa

$200+
 1 100%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 23, 2012.